Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT (Unaudited)

v3.7.0.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT (Unaudited) - 6 months ended Jun. 30, 2017 - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Deficit Accumulated [Member]
Total
Beginning balance, shares at Dec. 31, 2016 199,045,026      
Beginning balance, value at Dec. 31, 2016 $ 199,045 $ 103,716,955 $ (105,274,000) $ (1,358,000)
Common stock issued on exercise of warrants, shares 605,000      
Common stock issued on exercise of warrants, value $ 605 60,395   61,000
Common stock issued on conversion of notes payable, shares issued 24,858,380      
Common stock issued on conversion of notes payable, value $ 24,858 1,222,142   1,247,000
Fair value of warrants and beneficial conversion feature of issued convertible notes   1,469,000   1,469,000
Fair value of options and warrants issued as compensation   535,000   535,000
Net loss     (3,330,000) (3,330,000)
Ending balance, shares at Jun. 30, 2017 224,508,406      
Ending balance, value at Jun. 30, 2017 $ 224,508 $ 107,003,492 $ (108,604,000) $ (1,376,000)